BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2674458)

  • 1. Carboplatin substitution for cisplatin in the treatment of ovarian carcinoma--a word of caution.
    McGuire WP; Abeloff MD
    J Natl Cancer Inst; 1989 Oct; 81(19):1438-9. PubMed ID: 2674458
    [No Abstract]   [Full Text] [Related]  

  • 2. Carboplatin.
    Med Lett Drugs Ther; 1989 Sep; 31(800):83-4. PubMed ID: 2671623
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing cisplatin and carboplatin.
    Neijt JP; van Houwelingen JC
    J Natl Cancer Inst; 1990 Mar; 82(5):434-5. PubMed ID: 2406453
    [No Abstract]   [Full Text] [Related]  

  • 4. Carboplatin versus cisplatin.
    Tighe M; Goodman S
    Lancet; 1988 Dec; 2(8624):1372-3. PubMed ID: 2904096
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating ovarian cancer.
    Sweetenham JW; Mead GM; Whitehouse JM; Williams CJ
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1435-6. PubMed ID: 3099901
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.
    Mangioni C; Bolis G; Pecorelli S; Bragman K; Epis A; Favalli G; Gambino A; Landoni F; Presti M; Torri W
    J Natl Cancer Inst; 1989 Oct; 81(19):1464-71. PubMed ID: 2674459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JM8 (cisplatin analogue) alone for previously untreated advanced ovarian carcinoma.
    Neijt JP; Nortier JW; Vendrik CP; Struyvenberg A
    Lancet; 1983 May; 1(8333):1109-10. PubMed ID: 6133142
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease.
    Lund B; Hansen M; Hansen OP; Hansen HH
    J Clin Oncol; 1989 Oct; 7(10):1469-73. PubMed ID: 2674334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whither carboplatin.
    J Clin Oncol; 1987 Jun; 5(6):984-6. PubMed ID: 3295133
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose cisplatin and high dose carboplatin in refractory ovarian cancer.
    Ozols RF; Behrens BC; Ostchega Y; Young RC
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():59-65. PubMed ID: 3910223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin in refractory epithelial ovarian cancer.
    Kavanagh JJ; Nicaise C
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):45-8. PubMed ID: 2655098
    [No Abstract]   [Full Text] [Related]  

  • 12. Carboplatin in the first-line chemotherapy of ovarian cancer.
    Alberts DS; Canetta R; Mason-Liddil N
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):54-60. PubMed ID: 2406922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.
    Speyer JL; Beller U; Colombo N; Sorich J; Wernz JC; Hochster H; Green M; Porges R; Muggia FM; Canetta R
    J Clin Oncol; 1990 Aug; 8(8):1335-41. PubMed ID: 2199620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal dosing with carboplatin.
    Ozols RF
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):14-8. PubMed ID: 2655094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin in the treatment of ovarian cancer.
    Alberts DS; Mason-Liddil N
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):19-26. PubMed ID: 2655095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds.
    Gore ME; Fryatt I; Wiltshaw E; Dawson T
    Gynecol Oncol; 1990 Feb; 36(2):207-11. PubMed ID: 2404837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of platinum dose intensity in the management of ovarian cancer.
    Markman M
    J Cancer Res Clin Oncol; 1993; 119(9):511-2. PubMed ID: 8325902
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin.
    Muggia FM
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):7-13. PubMed ID: 2655099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs and experimental approaches in ovarian cancer treatment.
    Thigpen JT; Vance RB; Balducci L; Khansur T
    Semin Oncol; 1984 Sep; 11(3):314-26. PubMed ID: 6435251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.